EUVIMEDEUVIMED entdecken
Crossref

iDose TR — A Travoprost Implant for Glaucoma

The Medical Letter on Drugs and Therapeutics · 2024

DOI: 10.58347/tml.2024.1701d ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2024. Hauptthemen laut MEDLINE: Glaucoma, Travoprost, Drug Implants, Antihypertensive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FDA has approved iDose TR (Glaukos), an intracameral implant containing the prostaglandin analog (PGA) travoprost, for reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlaucomaTravoprostDrug ImplantsAntihypertensive AgentsHumansIntraocular Pressure

Stichwörter der Autor:innen

DurystaRhopressaTravatan Zadverse effectsefficacyeyeglaucomaiDose TRlactationnetarsudilpregnancysafetytravoprost

Substanzen

TravoprostDrug ImplantsAntihypertensive Agents

Zitieren

APA

(2024). iDose TR — A Travoprost Implant for Glaucoma. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2024.1701d

Vancouver

iDose TR — A Travoprost Implant for Glaucoma. The Medical Letter on Drugs and Therapeutics. 2024. doi:10.58347/tml.2024.1701d

BibTeX
@article{euvimed2024,
  title = {iDose TR — A Travoprost Implant for Glaucoma},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2024},
  doi = {10.58347/tml.2024.1701d}
}
Kostenlos starten →